140 related articles for article (PubMed ID: 8837338)
1. Adenocarcinoma simulating mesothelioma.
Corrin B; Dewar A
Ultrastruct Pathol; 1996; 20(4):327-9. PubMed ID: 8837338
[TBL] [Abstract][Full Text] [Related]
2. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
Ylagan LR; Zhai J
Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
[TBL] [Abstract][Full Text] [Related]
3. Mucin-positive epithelial mesotheliomas: a histochemical, immunohistochemical, and ultrastructural comparison with mucin-producing pulmonary adenocarcinomas.
Hammar SP; Bockus DE; Remington FL; Rohrbach KA
Ultrastruct Pathol; 1996; 20(4):293-325. PubMed ID: 8837337
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
5. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
Leong AS; Stevens MW; Mukherjee TM
Semin Diagn Pathol; 1992 May; 9(2):141-50. PubMed ID: 1609156
[TBL] [Abstract][Full Text] [Related]
6. The combination of CEA, EMA, and BerEp4 and hyaluronan analysis specifically identifies 79% of all histologically verified mesotheliomas causing an effusion.
Dejmek A; Hjerpe A
Diagn Cytopathol; 2005 Mar; 32(3):160-6. PubMed ID: 15690331
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesothelioma.
Suzuki H; Hirashima T; Kobayashi M; Sasada S; Okamoto N; Uehara N; Tamiya M; Matsuura Y; Morishita N; Kawase I
Anticancer Res; 2010 Oct; 30(10):4343-6. PubMed ID: 21036761
[TBL] [Abstract][Full Text] [Related]
8. Mucin-positive epithelial mesothelioma.
MacDougall DB; Wang SE; Zidar BL
Arch Pathol Lab Med; 1992 Aug; 116(8):874-80. PubMed ID: 1341882
[TBL] [Abstract][Full Text] [Related]
9. Foamy cell mesothelioma.
Cavazza A; Pasquinelli G; Agostini L; Leslie KO; Colby TV
Histopathology; 2002 Oct; 41(4):369-71. PubMed ID: 12383224
[No Abstract] [Full Text] [Related]
10. Pleural mesothelioma in situ and its adenocarcinoma simulator.
Bono F
Int J Surg Pathol; 2010 Dec; 18(6):519-20. PubMed ID: 21081535
[No Abstract] [Full Text] [Related]
11. Deciduoid pleural mesothelioma affecting a young female without prior asbestos exposure.
Gloeckner-Hofmann K; Zhu XZ; Bartels H; Feller AC; Merz H
Respiration; 2000; 67(4):456-8. PubMed ID: 10940805
[TBL] [Abstract][Full Text] [Related]
12. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
Brown RW; Clark GM; Tandon AK; Allred DC
Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
[TBL] [Abstract][Full Text] [Related]
13. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
Sakuma N; Kamei T; Ishihara T
Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
[TBL] [Abstract][Full Text] [Related]
15. Panel for distinction between mesothelioma and adenocarcinoma: confidence limits for a small study.
Bishop PW
Histopathology; 2001 Dec; 39(6):639-40. PubMed ID: 11903583
[No Abstract] [Full Text] [Related]
16. Pulmonary adenocarcinoma simulating malignant mesothelioma.
Tang P; Vatsia SK; Teichberg S; Kahn E
Arch Pathol Lab Med; 2001 Dec; 125(12):1598-600. PubMed ID: 11735699
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical differential diagnosis of pleural effusions, with emphasis on malignant mesothelioma.
Wick MR; Moran CA; Mills SE; Suster S
Curr Opin Pulm Med; 2001 Jul; 7(4):187-92. PubMed ID: 11470972
[TBL] [Abstract][Full Text] [Related]
18. My approach to the diagnosis of mesothelial lesions.
Butnor KJ
J Clin Pathol; 2006 Jun; 59(6):564-74. PubMed ID: 16731600
[TBL] [Abstract][Full Text] [Related]
19. Glycogen-rich mesothelioma.
Ordóñez NG; Mackay B
Ultrastruct Pathol; 1999; 23(6):401-6. PubMed ID: 10626691
[TBL] [Abstract][Full Text] [Related]
20. The use of the monoclonal antibody mesothelin in the diagnosis of malignant mesothelioma in pleural biopsies.
Galloway ML; Murray D; Moffat DF
Histopathology; 2006 May; 48(6):767-9. PubMed ID: 16681698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
